Document is current
Any future updates will be listed below
-
Authors
Uddin, Md Mesbah
Zhou, Ying
Bick, Alexander G.
Burugula, Bala Bharathi
Jaiswal, Siddhartha
Desai, Pinkal
Honigberg, Michael C.
Love, Shelly-Ann
Barac, Ana
Hayden, Kathleen M.
Manson, JoAnn E.
Whitsel, Eric A.
Kooperberg, Charles
Natarajan, Pradeep
Reiner, Alexander P.
Kitzman, Jacob O.
- License Information
-
More Information
Article History
Received: 25 March 2022
Accepted: 8 May 2022
First Online: 24 May 2022
Declarations
:
: Human samples were obtained with informed consent, and our study was reviewed and approved by the Fred Hutchinson Cancer Center Institutional Review Board (IRB #10186).
: Not applicable.
: All unrelated to the present work: S.J. is a consultant to Novartis, Roche Genentech, AVRO Bio, and Foresite Labs, and on the scientific advisory board for Bitterroot Bio; S.J., P.N., and A.G.B. are founders, equity holders, and/or scientific advisory board members of TenSixteen Bio; J.O.K is an advisor to MyOme Inc. P.N. reports grant support from Amgen, Apple, AstraZeneca, Boston Scientific, and Novartis, spousal employment and equity at Vertex, consulting income from Apple, AstraZeneca, Novartis, Genentech / Roche, Blackstone Life Sciences, and Foresite Labs, and is a scientific advisor board member of geneXwell, all unrelated to this work. M.C.H. reports consulting fees from CRISPR Therapeutics. All other authors declare that they have no competing interests.
